Ipamorelin
Definition
Ipamorelin is a pentapeptide (5 amino acids) that acts as a selective growth hormone secretagogue receptor (GHSR) agonist — binding ghrelin receptors in the pituitary to stimulate growth hormone release. Its clinical interest stems from its selectivity: unlike earlier generation GHRPs (GHRP-2, GHRP-6), ipamorelin does not significantly elevate cortisol, prolactin, or ACTH at standard doses, reducing the risk of stimulating unwanted hormonal pathways. It produces pulsatile GH release that closely mimics natural GH secretion patterns. Potential benefits studied include improved body composition, enhanced sleep quality (GH is secreted predominantly during deep sleep), accelerated recovery, and anti-aging effects. Like CJC-1295, it is not FDA-approved for these indications and is subject to evolving regulatory constraints.
Frequently Asked Question
Why Ipamorelin Matters
How Spokmed Company Uses It
Ipamorelin may be considered at SPOKEmed as part of individualized longevity and body composition protocols, subject to current regulatory availability and individual patient evaluation.
